{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T21:58:47Z","timestamp":1772575127007,"version":"3.50.1"},"reference-count":34,"publisher":"American Society of Clinical Oncology (ASCO)","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Oncol Pract"],"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>As oncologic precision medicine develops, there is concern that tumor genomic profiling among Black patients and other underrepresented demographics will lag and amplify health disparities. We evaluate whether a precision medicine navigator (PMN), a clinical navigator specialized in obtaining tumor genomic testing for patients, is associated with increased genomic testing rates and whether this is the case among Black patients and other disadvantaged groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We retrospectively reviewed prostate cancer consults within one health care system from November 2, 2021, to January 2, 2023. We compared the proportion of patients who received genomic testing in the 7 months before the PMN start (pre-PMN) to the 7 months afterward (post-PMN). Binary logistic regression was used to calculate the odds of receiving testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The sample included 693 patients, 311 pre-PMN and 382 post-PMN. Racial distribution and clinical stage were well-balanced between the pre- and post-PMN groups. From pre- to post-PMN, the proportion of patients receiving testing increased from 18% to 70% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0002). Significant increases in testing post-PMN occurred among Black patients, lower median income patients, patients with Medicare\/Medicaid, and community hospital patients. However, utilization post-PMN was significantly higher in non-Black compared with Black patients, 75.4% and 58.5%, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0006).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>For patients with prostate cancer, the presence of a PMN is associated with increased rates of genomic testing overall, including among Black patients and other groups that experience health inequities. Utilization post-PMN was significantly lower in Black patients compared with non-Black patients. More research is needed into why Black patients show lower rates of genomic testing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/op-25-00983","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T20:59:28Z","timestamp":1772571568000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Impact of a Precision Medicine Navigator on Genomic Test Utilization in Black Patients With Prostate Cancer"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2863-5233","authenticated-orcid":true,"given":"Alexander J.","family":"Allen","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bansi","family":"Savla","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Datnow-Martinez","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Mendes","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-6515","authenticated-orcid":true,"given":"Sophia C.","family":"Kamran","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Ambs","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8730-5435","authenticated-orcid":true,"given":"Zachery","family":"Keepers","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Eggleston","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaysee","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8221-1631","authenticated-orcid":true,"given":"Jason K.","family":"Molitoris","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-4707","authenticated-orcid":true,"given":"Matthew J.","family":"Ferris","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshar N.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaker H.","family":"Rana","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Kunaprayoon","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack J.","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi K.","family":"Benda","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendla K.","family":"Citron","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elai","family":"Davicioni","sequence":"additional","affiliation":[{"name":"Veracyte Biosciences, San Diego, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2588-1575","authenticated-orcid":true,"given":"Mark V.","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-7564","authenticated-orcid":true,"given":"Soren M.","family":"Bentzen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"},{"name":"Division of Biostatistics and Bioinformatics, University of Maryland Greenebaum Cancer Center, Baltimore, MD"},{"name":"Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-7728","authenticated-orcid":true,"given":"Taofeek K.","family":"Owonikoko","sequence":"additional","affiliation":[{"name":"University of Maryland Greenebaum Cancer Center, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William F.","family":"Regine","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1484-8507","authenticated-orcid":true,"given":"Young","family":"Kwok","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0147-0376","authenticated-orcid":true,"given":"Phuoc T.","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4612-7341","authenticated-orcid":true,"given":"Melissa A.L.","family":"Vyfhuis","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34433"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.12.035"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.04.010"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.7671"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02768"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26797"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-019-0197-3"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00351-6"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/PO.21.00340"},{"key":"e_1_3_8_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.34208"},{"key":"e_1_3_8_12_2","first-page":"e1867","article-title":"Racial disparity in the genomics of precision oncology of prostate cancer","volume":"6","author":"Le T","year":"2023","unstructured":"Le T, Rojas PS, Fakunle M, et al: Racial disparity in the genomics of precision oncology of prostate cancer. Cancer Rep (Hoboken) 6:e1867, 2023","journal-title":"Cancer Rep (Hoboken)"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2018.05.028"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01854"},{"key":"e_1_3_8_15_2","volume-title":"Schaufeld Program for Prostate Cancer in Black Men","unstructured":"Schaufeld Program for Prostate Cancer in Black Men, Brady Urological Institute, Johns Hopkins Medicine. Baltimore, MD. https:\/\/www.hopkinsmedicine.org\/brady-urology-institute\/conditions-and-treatments\/prostate-cancer\/prostate-cancer-black-men"},{"key":"e_1_3_8_16_2","volume-title":"East Baltimore Church Saving Black Men One Screening at a Time","author":"Taylor A","unstructured":"Taylor A: East Baltimore Church Saving Black Men One Screening at a Time. AFRO American Newspapers, August 2, 2018. https:\/\/afro.com\/east-baltimore-church-saving-black-men-one-screening-at-a-time\/"},{"key":"e_1_3_8_17_2","volume-title":"US Department of Health and Human Services, Office of Minority Health. Black\/African American Health","year":"2025","unstructured":"US Department of Health and Human Services, Office of Minority Health. Black\/African American Health. Washington, DC, US Department of Health and Human Services. 2025. https:\/\/minorityhealth.hhs.gov\/blackafrican-american-health"},{"key":"e_1_3_8_18_2","volume-title":"Health Coverage by Race and Ethnicity. Kaiser Family Foundation (KFF)","author":"Hill L","year":"2025","unstructured":"Hill L, Ndugga N, Artiga S, et al: Health Coverage by Race and Ethnicity. Kaiser Family Foundation (KFF). 2025. https:\/\/www.kff.org\/racial-equity-and-health-policy\/health-coverage-by-race-and-ethnicity\/"},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16875"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-0917"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1826-2"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00431"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.6058"},{"key":"e_1_3_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.04.003"},{"key":"e_1_3_8_25_2","volume-title":"Insurance Coverage & Billing\u2014Decipher\u00ae Prostate","author":"Veracyte, Inc","year":"2026","unstructured":"Veracyte, Inc: Insurance Coverage & Billing\u2014Decipher\u00ae Prostate. Decipher Bio (Decipher\u00ae Prostate Patients). 2026. https:\/\/decipherbio.com\/decipher-prostate\/patients\/insurance-coverage-billing\/"},{"key":"e_1_3_8_26_2","first-page":"31","volume-title":"The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity","author":"Flaubert JL","year":"2021","unstructured":"Flaubert JL, Le Menestrel S, Williams DR, et al: 2, Social determinants of health and health equity. The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity. Washington, DC: National Academies Press (US); 31-58, 2021"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnma.2019.01.006"},{"key":"e_1_3_8_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00547-4"},{"key":"e_1_3_8_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.1723"},{"key":"e_1_3_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.11.044"},{"key":"e_1_3_8_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-021-00428-y"},{"key":"e_1_3_8_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-019-0167-9"},{"key":"e_1_3_8_33_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0050"},{"key":"e_1_3_8_34_2","volume-title":"Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)","author":"NRG Oncology (Sponsor)","year":"2026","unstructured":"NRG Oncology (Sponsor): Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE). ClinicalTrials.gov Identifier: NCT05050084, 2026. https:\/\/clinicaltrials.gov\/study\/NCT05050084"},{"key":"e_1_3_8_35_2","volume-title":"Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT)","author":"NRG Oncology (Sponsor)","year":"2026","unstructured":"NRG Oncology (Sponsor): Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT). ClinicalTrials.gov Identifier: NCT04513717. 2026. https:\/\/clinicaltrials.gov\/study\/NCT04513717"}],"container-title":["JCO Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/OP-25-00983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T20:59:30Z","timestamp":1772571570000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/OP-25-00983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":34,"alternative-id":["10.1200\/OP-25-00983"],"URL":"https:\/\/doi.org\/10.1200\/op-25-00983","relation":{},"ISSN":["2688-1527","2688-1535"],"issn-type":[{"value":"2688-1527","type":"print"},{"value":"2688-1535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"2025-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"OP-25-00983"}}